Planet Labs PBC
General ticker "PL" information:
- Sector: Industrials
- Industry: Aerospace & Defense
- Capitalization: $2.0B (TTM average)
Planet Labs PBC follows the US Stock Market performance with the rate: 53.2%.
Estimated limits based on current volatility of 4.9%: low 24.80$, high 27.37$
Factors to consider:
- Total employees count: 1180 (+7.3%) as of 2024
- US accounted for 44.7% of revenue in the fiscal year ended 2024-01-31
- Top business risk factors: Limited operating history, Market competition, Satellite and infrastructure failures, Economic downturns and volatility, Geopolitical risks
- Current price 263.9% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-01-31 to 2027-01-31
- 2025-01-31 to 2026-01-31 estimated range: [3.22$, 6.86$]
- 2026-01-31 to 2027-01-31 estimated range: [2.58$, 5.64$]
Financial Metrics affecting the PL estimates:
- Positive: with PPE of -25.1 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -0.93 <= 0
- Positive: Investing cash flow per share per price, % of 3.77 > -0.63
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Shareholder equity ratio, % of 69.63 > 64.37
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of -1.51 <= -0.18
- Positive: -0.04 < Industry operating cash flow per share per price (median), % of 1.24
- Positive: 2.99 < Industry operating profit margin (median), % of 3.18
Short-term PL quotes
Long-term PL plot with estimates
Financial data
| YTD | 2023-01-31 | 2024-01-31 | 2025-01-31 |
|---|---|---|---|
| Operating Revenue | $191.26MM | $220.70MM | $244.35MM |
| Operating Expenses | $366.93MM | $390.44MM | $360.47MM |
| Operating Income | $-175.68MM | $-169.75MM | $-116.12MM |
| Non-Operating Income | $14.56MM | $30.05MM | $-4.61MM |
| R&D Expense | $110.92MM | $116.34MM | $101.01MM |
| Income(Loss) | $-161.12MM | $-139.69MM | $-120.74MM |
| Taxes | $0.85MM | $0.81MM | $2.46MM |
| Profit(Loss)* | $-161.97MM | $-140.51MM | $-123.20MM |
| Stockholders Equity | $576.10MM | $518.02MM | $441.29MM |
| Assets | $752.72MM | $702.00MM | $633.80MM |
| Operating Cash Flow | $-73.93MM | $-50.71MM | $-14.37MM |
| Capital expenditure | $12.76MM | $42.41MM | $44.30MM |
| Investing Cash Flow | $-242.26MM | $-33.59MM | $57.91MM |
| Financing Cash Flow | $7.86MM | $-1.60MM | $-15.54MM |
| Earnings Per Share** | $-0.61 | $-0.50 | $-0.42 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.